Circassia Pharmaceuticals (GB:NIOX) has released an update.
NIOX Group PLC has successfully completed its tender offer, purchasing 26.25 million ordinary shares at 80 pence each, returning approximately £21 million to shareholders. This move, involving significant shareholders like Harwood Capital and AstraZeneca, is deemed a related party transaction but is considered fair by independent directors. Post-tender, the company will have 397.88 million shares with voting rights, providing a new baseline for shareholder interest calculations.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
